Mark Feitelson

Professor at Temple University

SFA Therapeutics· Summer 2021🇺🇸 Philadelphia, Pennsylvania, United States

in LinkedIn 𝕏 @feitelson

2007Professor· Temple University

In tech · since 1982

Company

Temple University

Role

Professor

current

Stage

—

no public source

Raised

—

no public source

Based

—

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

SFA Therapeutics

Regulating the immune system to block cancer & autoimmune diseases

Summer 2021

Experience

Career

Temple University
Professor · 2007 – Present
2007
Thomas Jefferson University
Professor of Pathology, Anatomy and Cell Biology · 1991 – 2007
1991
Fox Chase Cancer Center
Associate Member · Greater Philadelphia Area · 1982 – 1991
1982
Stanford University School of Medicine
American Cancer Society Postdoctoral Fellow · Palo Alto, California · 1979 – 1982
1982

Bio

Mark Feitelson received his Ph.D. in Microbiology/Immunology from UCLA. He began his work with hepatitis B at Stanford University, and was then recruited to the Fox Chase Cancer Center by Dr. Baruch Blumberg (Nobel laureate). In 1991, Dr. Feitelson moved to Thomas Jefferson University, and in 2007, to Temple University as a Professor of Biology. His work has been supported by NIH, industry and foundations. He has more than 150 publications and 180 abstracts. He is also CSO of SFA Therapeutics.